Sphingolipids in Cancer Therapy and Angiogenesis
Sphingolipids in Cancer Therapy and Angiogenesis
批准号:
7269477
负责人:
YUSUF AWNI HANNUN
金额:
$107.17万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2008-07-31
关键词:
1,2-diacylglycerol6-MercaptopurineABL1 geneAccountingActinsAcuteAcylationAdaptor Signaling ProteinAddressAdenocarcinoma CellAdherens JunctionAdriamycin PFSAdverse effectsAffectAffinityAgonistAlternative SplicingAmsacrineAnabolismAntibioticsAntiemeticsAntineoplastic AgentsApoptosisApoptosis PromoterApoptosis RegulatorApoptoticAppendixAra-CAreaAttenuatedBindingBinding ProteinsBiochemicalBiochemical GeneticsBiochemical PathwayBiochemistryBiologicalBiopsy SpecimenBleomycinBlood PlateletsBlood VesselsBlood capillariesBone MarrowBreast Cancer CellBreast CarcinomaBypassBystander EffectCCL4 geneCalciumCamptothecinCancer BiologyCaspaseCatabolismCathepsinsCell Cycle ArrestCell Cycle ProgressionCell DeathCell LineCell Surface ReceptorsCell SurvivalCell membraneCell physiologyCellsCeramidaseCeramide glucosyltransferaseCeramidesCessation of lifeChemistryChemotherapy-Oncologic ProcedureChildhoodChildhood Acute Lymphocytic LeukemiaCisplatinClassClinicalCoenzyme AColchicineCombination ChemotherapyComplexCoupledCyclic AMPCyclophosphamideCyclophosphamide/VincristineCysteine ProteaseCytarabineCytoprotectionCytotoxic ChemotherapyCytotoxic agentDNADNA DamageDNA FragmentationDNA IntercalationDactinomycinDataData SetDaunorubicinDefectDegradation PathwayDeoxyuridineDevelopmentDexamethasoneDexamethasone/VincristineDiacylglycerol KinaseDiglyceridesDihydrosphingosineDiseaseDisease ProgressionDisease regressionDisruptionDissectionDistalDoxorubicinDoxorubicin/EtoposideDrug resistanceEGF geneEffectivenessEffector CellEicosanoidsElevationEmbryoEndocytosisEndopeptidasesEndothelial CellsEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesEphrinsEquilibriumEsophageal Squamous Cell CarcinomaEtoposideEventExtended FamilyExtracellular MatrixExtracellular Signal Regulated KinasesFamilyFluorouracilFocal AdhesionsFoundationsFumonisin B1FumonisinsFunctional disorderG-Protein-Coupled ReceptorsGangliosidesGenerationsGenesGenetic TranscriptionGerm CellsGlioblastomaGlucoseGlucosylceramidesGlycerolipid Metabolism PathwayGlycolipidsGoalsGolgi ApparatusGrowthGrowth FactorGuanosine Triphosphate PhosphohydrolasesHRAS geneHandHeadHeat Stress DisordersHeat-Shock ResponseHeatingHelix-Turn-Helix MotifsHematologic NeoplasmsHereditary Sensory NeuropathyHigh Dose ChemotherapyHomebound PersonsHomologous GeneHormonesHourHumanHydrolaseHydrolysisHypoxiaIn VitroIndividualInduction of ApoptosisInflammatoryInhibition of ApoptosisInjuryInstructionInterleukin-1Internucleosomal DNA FragmentationInterventionInvestigationIonizing radiationJUN geneKineticsKnockout MiceKnowledgeLaboratoriesLeadLearningLeukemic CellLigandsLinkLipaseLipid ChemistryLipidsLipoproteinsLiteratureLungLyaseLymphomaLysophospholipidsLysosomesMDM2 geneMDM2 geneMalignant Epithelial CellMalignant NeoplasmsMalignant neoplasm of lungMammalian CellMeasuresMediatingMediator of activation proteinMessenger RNAMetabolicMetabolic PathwayMetabolismMethodsMethylnitrosoureaMicrofilamentsMicrotubulesMitochondriaMitogen-Activated Protein KinasesMitomycinModalityMolecularMusMutationMycotoxinsNF-kappa BNamesNatural regenerationNeoplasm MetastasisNon-Hodgkin&aposs LymphomaNormal tissue morphologyNutrientObject AttachmentOperative Surgical ProceduresOutcomeOutputOvarianOvarian Surface Epithelial-Stromal TumorOxidation-ReductionPaclitaxelPathway interactionsPatientsPatternPeptide HydrolasesPersonal SatisfactionPhasePhenotypePhorbol EstersPhosphatidate PhosphatasePhosphatidic AcidPhospholipase DPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysical condensationPhysiologicalPlantsPlasmaPlatelet ActivationPlatelet-Derived Growth FactorPlatinumPlayPloidiesPoly(ADP-ribose) PolymerasesPreventionPrincipal InvestigatorProcessProductionProtein BiosynthesisProtein DephosphorylationProtein KinaseProtein Kinase CProtein Kinase C InhibitorProtein OverexpressionProtein Phosphatase 2A Regulatory Subunit PR53Protein Serine/Threonine PhosphataseProtein Tyrosine KinaseProtein phosphataseProteinsPublishingRNARNA SplicingRadiationRadiation therapyRadioReactionReceptor Protein-Tyrosine KinasesRegulationRelative (related person)ReportingResearchResearch PersonnelResistanceRetinoblastoma GenesRhabdomyosarcomaRoleRouteSaccharomyces cerevisiaeSafingolSchemeSeriesSerineSerpinsSerumSignal TransductionSignal Transduction PathwaySignaling MoleculeSiteSmooth Muscle MyocytesSolid NeoplasmSourceSpecificitySphingolipidsSphingomyelinaseSphingomyelinsSphingosineSphingosine-1-Phosphate ReceptorStimulusStressStress FibersStudy SubjectSulfoglycosphingolipidsT-Cell LymphomaT-LymphocyteTP53 geneTelomeraseTemperatureTestingTetradecanoylphorbol AcetateTherapeuticThinkingTissue SampleTissuesTopoisomerase-II InhibitorToxic effectTranscriptTransglutaminasesTretinoinTumor AngiogenesisTumor BiologyTumor Cell BiologyTumor Cell LineTumor MarkersTumor Necrosis Factor Ligand Superfamily Member 6Type II Epithelial Receptor CellUbiquitinUp-RegulationVM26Vascular Endothelial Growth FactorsVascular remodelingVascularizationVincristineViralViral ProteinsWithdrawalWorkYeastsacid sphingomyelinaseacidic sphingomyelinaseanalogangiogenesisasparaginaseattenuationbasebcr-abl Fusion Proteinsbiological adaptation to stressc-abl Proto-Oncogenescancer cellcancer therapycapillarycasein kinase IIcaspase-3caspase-9cell behaviorcell injurycell killingcell typeceramide 1-phosphateceramide-activated protein phosphatasechemotherapeutic agentchemotherapyconceptcytochrome ccytokinecytotoxiccytotoxicitydeacylationdesigndihydroceramidedihydroceramide desaturasedihydroceramide synthasedrug sensitivityendonucleaseextracellularfatty aldehydefrontiergain of functiongene therapygenetic analysisgrowth promoting activityhuman AMID proteinhuman KSR proteinhuman MAPK14 proteinhydroxyureahypoxia inducible factor 1in vivoinhibitor/antagonistinorganic phosphateinsightinterestirradiationkillingsleukemialipid mediatorlysophosphatidic acidmacromoleculemalignant breast neoplasmmalignant stomach neoplasmmembermitogen-activated protein kinase p38neoplastic cellneuron lossnovelnovel strategiesoutcome forecastp21 activated kinasepermeasephosphoethanolaminephytosphingosineprogramspromoterreceptorrelease of sequestered calcium ion into cytoplasmrepairedresponserhosenescencesensorserine palmitoyltransferasesphingomyelin synthasesphingosine 1-phosphatesphingosine kinasesphingosine phosphatasetherapeutic angiogenesistherapeutic targetthymocytetissue culturetranscription factortumortumor growthuptakevasculogenesis
中文摘要
描述(由申请人提供):鞘脂代谢途径提供了非常丰富的生物活性分子网络,其新兴功能表明在细胞功能调节中起关键作用。特别是,已发表的和初步的结果表明,全球的假设,神经酰胺形成相关的途径在细胞因子和化疗诱导的癌细胞死亡中发挥关键作用,而鞘脂鞘氨醇-1-磷酸(SIP)可能成为肿瘤新血管形成的关键和新的调节剂。这一总体假设将通过3个不同项目的活动来实现:项目1将解决特定假设,即神经酰胺的从头合成和鞘磷脂水解定义了两种不同的神经酰胺形成途径,这两种途径通过两种不同的机制介导协同肿瘤细胞死亡。项目2将检验特定假设,即敏化未感染和/或耐药肿瘤细胞的能力(通过添加反义分子、化疗或诱导神经酰胺水平的药物)将促进更多的促凋亡表型,这将促进旁观者活性并实现更大的肿瘤细胞杀伤。项目3将验证鞘氨醇激酶及其产物SIP调节肿瘤血管生成的假设,抑制这一通路可以抑制肿瘤血管生成。这3个项目将得到一个行政核心和一个独特的脂质组学核心的支持,该核心将提供分析和合成脂质化学。这些互动研究的结果将把细胞生物化学(鞘脂代谢)的最后前沿带入癌症生物学研究,对癌细胞死亡和肿瘤血管生成产生重要而独特的见解。这些研究还将导致鉴定用于癌症治疗的新策略,其旨在诱导癌细胞死亡和/或抑制肿瘤血管生成。
英文摘要
DESCRIPTION (provided by applicant): Pathways of sphingolipid metabolism provide a very rich network of bioactive molecules whose emerging functions suggest key roles in the regulation of cell function. In particular, published and preliminary results suggest the global hypothesis that pathways linked to ceramide formation play key roles in cytokine- and chemotherapy-induced cancer cell death whereas the sphingolipid sphingosine-l-phosphate (SIP) may emerge as a key and novel regulator of tumor neo-vascularization. This overall hypothesis will be approached through the activities of 3 distinct projects: Project 1 will address the specific hypothesis that the de novo synthesis of ceramide and sphingomyelin hydrolysis define two distinct pathways of ceramide formation which mediate synergistic tumor cell death through two distinct mechanisms. Project 2 will test the specific hypothesis that the ability to sensitize uninfected and/or resistant tumor cells (by addition of antisense molecules, chemotherapy, or agents that induce ceramide levels), would promote a more proapoptotic phenotype, and this would facilitate bystander activity and achieve greater tumor cell killing. Project 3 will test the hypothesis that sphingosine kinase and its product SIP regulate tumor angiogenesis, and inhibiting this pathway could inhibit tumor angiogenesis. These 3 projects will be supported by an Administrative Core and by a unique Lipidomics Core that will provide analytical and synthetic lipid chemistry. The results of these interactive studies would bring this last frontier of cellular biochemistry (sphingolipid metabolism) into cancer biology research, generating significant and unique insights into cancer cell death and tumor angiogenesis. The studies should also result in the identification of novel strategies for cancer therapeutics aimed at inducing cancer cell death and/or inhibition of tumor angiogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protein kinase C in Lung Cancer with mutant EGFR
-
批准号:10618917
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Protein kinase C in Lung Cancer with mutant EGFR
-
批准号:10454776
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Protein kinase C in Lung Cancer with mutant EGFR
-
批准号:9888660
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Ceramide Activated Protein Phosphatases
-
批准号:10208802
-
项目类别:
-
资助金额:$36.49万
-
财政年份:2018
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Ceramide Activated Protein Phosphatases
-
批准号:10434893
-
项目类别:
-
资助金额:$35.76万
-
财政年份:2018
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Ceramide Activated Protein Phosphatases
-
批准号:10734669
-
项目类别:
-
资助金额:$39.54万
-
财政年份:2018
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Neutral Sphingomyelinases and Bioactive Ceramides
-
批准号:10437811
-
项目类别:
-
资助金额:$73.6万
-
财政年份:2016
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Neutral Sphingomyelinases and Bioactive Ceramides
-
批准号:10640899
-
项目类别:
-
资助金额:$73.6万
-
财政年份:2016
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Neutral sphingomyelinases and bioactive ceramides
-
批准号:9071506
-
项目类别:
-
资助金额:$70.92万
-
财政年份:2016
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Diversity Supplement for Bernandie Jean: Neutral sphingomyelinases and bioactive ceramides
-
批准号:9752140
-
项目类别:
-
资助金额:$5.97万
-
财政年份:2016
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Admin Supplement: Neutral Sphingomyelinases and Bioactive Ceramides
-
批准号:10797322
-
项目类别:
-
资助金额:$4.86万
-
财政年份:2016
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Neutral Ceramidase in Colon Cancer
-
批准号:8577881
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2013
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Neutral Ceramidase in Colon Cancer
-
批准号:9081550
-
项目类别:
-
资助金额:$32.53万
-
财政年份:2013
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Neutral Ceramidase in Colon Cancer
-
批准号:8848356
-
项目类别:
-
资助金额:$32.53万
-
财政年份:2013
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
MOLECULAR IDENTITY OF MATURE LYSOSOMAL ACID SPHINGOMYELINASE
-
批准号:8365895
-
项目类别:
-
资助金额:$1.28万
-
财政年份:2011
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Thermo TSQ Quantum Access Mass Spectrometer
-
批准号:7794261
-
项目类别:
-
资助金额:$25.68万
-
财政年份:2010
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Support for the Charleston Ceramide Conference
-
批准号:8434291
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Support for the Charleston Ceramide Conference
-
批准号:8423722
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2009
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Support for the Charleston Ceramide Conference
-
批准号:8015580
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2009
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
Support for the Charleston Ceramide Conference
-
批准号:7761251
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:YUSUF AWNI HANNUN
-
依托单位:
海外基金